DUBLIN--(BUSINESS WIRE)--Mar 13, 2019--The "Gingivitis - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Gingivitis - Pipeline Insight, 2019 offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Gingivitis development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope of the Report

  • The report provides a snapshot of the pipeline development for the Gingivitis
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Gingivitis
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Gingivitis
  • The report also covers the dormant and discontinued pipeline projects related to Gingivitis

Companies Featured

  • TGV-Laboratories
  • VivaCell Biotechnology Espana

Topics Covered

1. Report Introduction

2. Gingivitis Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Gingivitis

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/ss3xch/gingivitis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190313005396/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dental

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/13/2019 08:00 AM/DISC: 03/13/2019 08:01 AM

http://www.businesswire.com/news/home/20190313005396/en

Copyright Business Wire 2019.